New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Daan Gene Co., Ltd.
002030.SZ
Shape
US Flag

SHZ

Unprofitable

EPS improving

Unprofitable

EPS improving

9B

Biotechnology

6.38CNY

Shape0.01 ( 0.16%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-7%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

13%

Quote Panel

Shape
Updated July 12, 2025
1W 1.27 % 1M 7.95 % 3M 13.32 % 1Y 28.89 %

Key Metrics

Shape
  • Market Cap

    8.75B


  • Shares Outstanding

    1.37B


  • Share in Float

    901.74M


  • Dividende

    0.02


  • Earning Date

    No Data


  • Price Target

    6.38


  • Average Volume

    16.30M


  • Beta

    0.67


  • Range

    4.71-7.32


  • Industry

    Biotechnology


  • Website

    https://www.daangene.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

002030.SZ

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2B

Shape1316%

2026-Revenue

$0.11

Shape184%

2026-EPS

$612M

Shape544%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-70%

0.36
vs 1.2

Q1.23

arrow
arrow

-98%

0.03
vs 1.2

Q2.23

arrow
arrow

-81%

0.26
vs 1.36

Q3.23

arrow
arrow

N/A

-0.04
vs 0.94

Q4.23

arrow
arrow

N/A

-0.18
vs NA

Q1.24

arrow
arrow

N/A

-0.26
vs 0.03

Q2.24

arrow
arrow

N/A

-0.03
vs 0.26

Q3.24

arrow
arrow

N/A

-0.07
vs -0.04

Q4.24

arrow
arrow

N/A

-0.30
vs -0.18

Q1.25

arrow
arrow

+115%

0.04
vs -0.26

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-19%

2.7B  vs 3.4B

Q1.23

arrow
arrow

-90%

341M  vs 3.4B

Q2.23

arrow
arrow

-94%

195.2M  vs 3.3B

Q3.23

arrow
arrow

-88%

306.1M  vs 2.7B

Q4.23

arrow
arrow

NA

333.4M  vs NA

Q1.24

arrow
arrow

-42%

197.1M  vs 341M

Q2.24

arrow
arrow

+3%

200.5M  vs 195.2M

Q3.24

arrow
arrow

-38%

189.2M  vs 306.1M

Q4.24

arrow
arrow

-21%

262M  vs 333.4M

Q1.25

arrow
arrow

-14%

169.1M  vs 197.1M

Return on EquityShape

status-upQoQ

Q2.23

arrow
arrow

+4%

0.04
vs 0

Q3.23

arrow
arrow

-1%

-0.01
vs 0.04

Q4.23

arrow
arrow

-3%

-0.03
vs -0.01

Q1.24

arrow
arrow

-4%

-0.04
vs -0.03

Q2.24

arrow
arrow

0%

-0.00
vs -0.04

Q3.24

arrow
arrow

-1%

-0.01
vs -0.00

Q4.24

arrow
arrow

-5%

-0.05
vs -0.01

Q1.25

arrow
arrow

+1%

0.01
vs -0.05

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News